Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.85B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$653M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$629M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.17B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$981M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$416M |
| 4 |
Amazon
AMZN
|
+$402M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.09% |
| 2 | Healthcare | 5.36% |
| 3 | Financials | 5.34% |
| 4 | Communication Services | 4.69% |
| 5 | Consumer Discretionary | 4.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
Pacira BioSciences
PCRX
$917M
| $300K | ﹤0.01% |
6,979
-14,559
| -68% | -$680K |
|
|
IMGN
4202
DELISTED
Immunogen Inc
IMGN
| $300K | ﹤0.01% |
62,520
-13,653
| -18% | -$82.8K |
|
|
GNBC
4203
DELISTED
Green Bancorp, Inc
GNBC
| $300K | ﹤0.01% |
17,507
-52,420
| -75% | -$1.01M |
|
4204
CALL
BorgWarner
BWA
$14B
| $299K | ﹤0.01% |
9,770
-1,931
| -17% | -$64.7K |
|
|
RLH
4205
DELISTED
Red Lions Hotel Corporation
RLH
| $299K | ﹤0.01% |
36,439
+29,685
| +440% | +$291K |
|
|
JCAP
4206
DELISTED
Jernigan Capital, Inc.
JCAP
| $299K | ﹤0.01% |
15,099
-4,884
| -24% | -$99.4K |
|
4207
MGP Ingredients
MGPI
$379M
| $297K | ﹤0.01% |
5,208
-11,610
| -69% | -$784K |
|
4208
CALL
CNX Resources
CNX
$5.28B
| $296K | ﹤0.01% |
25,900
-1,300
| -5% | -$17.9K |
|
4209
CALL
FMC
FMC
$1.27B
| $296K | ﹤0.01% |
4,612
-7,725
| -63% | -$542K |
|
|
EMBJ
4210
Embraer S.A. ADS
EMBJ
$13.4B
| $295K | ﹤0.01% |
13,339
-52,083
| -80% | -$1.11M |
|
4211
CALL
Teradata
TDC
$2.57B
| $295K | ﹤0.01% |
7,700
+7,600
| +7,600% | +$278K |
|
|
SPWR
4212
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $295K | ﹤0.01% |
90,704
+15,728
| +21% | +$65.4K |
|
4213
PUT
iShares MSCI Taiwan ETF
EWT
$11.5B
| $294K | ﹤0.01% |
9,300
+8,700
| +1,450% | +$289K |
|
4214
MarineMax
HZO
$1.15B
| $294K | ﹤0.01% |
16,046
-15,057
| -48% | -$314K |
|
4215
Ryanair
RYAAY
$30.5B
| $294K | ﹤0.01% |
10,300
+9,965
| +2,975% | +$318K |
|
4216
CALL
Pan American Silver
PAAS
$20B
| $293K | ﹤0.01% |
20,100
-17,000
| -46% | -$243K |
|
4217
RBC Bearings
RBC
$17.7B
| $293K | ﹤0.01% |
2,233
-16,024
| -88% | -$2.33M |
|
4218
CALL
Wendy's
WEN
$1.65B
| $293K | ﹤0.01% |
18,800
+14,200
| +309% | +$242K |
|
4219
Glaukos
GKOS
$10.9B
| $292K | ﹤0.01% |
5,203
-39,049
| -88% | -$2.35M |
|
4220
PUT
Olin
OLN
$2.18B
| $292K | ﹤0.01% |
14,500
+1,000
| +7% | +$21.3K |
|
4221
PUT
Teladoc Health
TDOC
$1.24B
| $292K | ﹤0.01% |
+5,900
| New | +$361K |
|
|
DCPH
4222
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $292K | ﹤0.01% |
13,908
+9,073
| +188% | +$223K |
|
4223
Cato Corp
CATO
$67.9M
| $291K | ﹤0.01% |
20,430
-14,375
| -41% | -$248K |
|
4224
Ecopetrol
EC
$35.3B
| $290K | ﹤0.01% |
18,254
+6,342
| +53% | +$136K |
|
|
SRCL
4225
CALL
DELISTED
Stericycle Inc
SRCL
| $290K | ﹤0.01% |
7,900
-8,500
| -52% | -$399K |
|
Similar funds
Barclays's Q4 2018 Portfolio in Review
As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, down from 8.3% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.
- Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
- Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
- Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
- Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
- Barclays opened 489 new positions and closed 777 in Q4 2018.
- Barclays's portfolio value fell 10% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.